Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Rammensee, HG (1995). Chemistry of peptides associated with MHC class I
and class II molecules. Curr. Opin. Immunol. 7: 85-96.
Rammensee, HG, Friede, T. and Stevanoviic, S. (1995). MHC ligands and
peptide motifs: first listing. Immunogenetics 41: 178-228.
Rammensee, HG, Bachmann, J., Emmerich, NP, Bachor, OA and Stevanovic, S.
(1999). SYFPEITHI: database for MHC ligands and peptide motifs.
Immunogenetics 50: 213-219.
Rao, J., Zhang, F., Donnelly, RJ, Spector, NL and Studzinski, GP. (1998).
Truncation of Sp1 transcription factor by myeloblastin in undifferentiated
HL60 cells. J. Cell Physiol. 175(2): 121-128.
Rao, NV, Rao, GV, Marshall, BC and Hoidal, JR (1996). Biosynthesis and
processing of proteinase 3 in U937 cells – processing pathways are distinct
from those of cathepsin G. J. Biol. Chem. 271: 2972-2978.
Rayman, P., Uzzo, RG, Kolenko, V., Bloom, T., Cathcart, MK, Molto, L.,
Novick, AC, Bukowski, RM, Hamilton, T. and Finke, JH (2000). Tumor-
induced dysfunction in interleukin-2 production and interleukin-2 receptor
signaling: a mechanism of immune escape. Cancer J. 6: 81-87.
Renkvist, N., Castelli, C., Robbins, PF and Parmiani, G. (2001). A listing of
human tumor antigens recognized by T cells. Cancer Immunol. Immunother.
50: 3-15.
Restifo, NP (2000). Not so Fas: Re-evaluating the mechanisms of immune
privilege and tumor escape. Nat. Med. 6: 493-495.
116